Saccomano Nicholas A
SEC CIK 1609284 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | Pres, CEO, Dir | 11.2K | — | $4,263 | 8 | 2024-10-04 | 2026-09-21 |
Transactions 8
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 16:54 | 2026-09-21 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.97 | -87 | 11.2K | -0.8% | -$258.76 | |
| 2026-06-24 19:29 | 2026-06-22 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $4.40 | -86 | 11.2K | -0.8% | -$378.08 | |
| 2026-03-24 | 2026-03-23 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $4.16 | -86 | 7,333 | -1% | -$357.76 | |
| 2025-12-23 | 2025-12-22 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.97 | -87 | 7,419 | -1% | -$258.39 | |
| 2025-09-24 | 2025-09-22 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.62 | -88 | 3,506 | -2% | -$230.56 | |
| 2025-06-25 | 2025-06-23 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.38 | -88 | 3,594 | -2% | -$209.44 | |
| M | 2025-04-08 | 2025-04-04+ | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.94 | -874 | 4,198 | -17% | -$2,570 |
| D | 2024-10-08 | 2024-10-04 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Pres, CEO, Dir | A - Grant | — | +4,556 | 4,556 | New | — |